Amir S Heravi1, Lacey H Etzkorn2, Jacek K Urbanek2, Ciprian M Crainiceanu2, Naresh M Punjabi3, Hiroshi Ashikaga4, Todd T Brown5, Matthew J Budoff6, Gypsyamber D'Souza7, Jared W Magnani8, Frank J Palella9, Ronald D Berger4, Katherine C Wu4, Wendy S Post4,7. 1. School of Medicine (A.S.H.), Johns Hopkins University, Baltimore, MD. 2. Department of Biostatistics (L.H.E., J.K.U., C.M.C.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 3. Division of Pulmonary and Critical Care Medicine (N.M.P.), Johns Hopkins University, Baltimore, MD. 4. Division of Cardiology, Department of Medicine (H.A., R.D.B., K.C.W., W.S.P.), Johns Hopkins University, Baltimore, MD. 5. Division of Endocrinology, Diabetes, and Metabolism (T.T.B.), Johns Hopkins University, Baltimore, MD. 6. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, CA (M.J.B.). 7. Department of Epidemiology (G.D.. W.S.P.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 8. Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, PA (J.W.M.). 9. Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (F.J.P.).
Abstract
BACKGROUND: People living with human immunodeficiency virus (HIV+) have greater risk for sudden arrhythmic death than HIV-uninfected (HIV-) individuals. HIV-associated abnormal cardiac repolarization may contribute to this risk. We investigated whether HIV serostatus is associated with ventricular repolarization lability by using the QT variability index (QTVI), defined as a log measure of QT-interval variance indexed to heart rate variance. METHODS: We studied 1123 men (589 HIV+ and 534 HIV-) from MACS (Multicenter AIDS Cohort Study), using the ZioXT ambulatory electrocardiography patch. Beat-to-beat analysis of up to 4 full days of electrocardiographic data per participant was performed using an automated algorithm (median analyzed duration [quartile 1-quartile 3]: 78.3 [66.3-83.0] hours/person). QTVI was modeled using linear mixed-effects models adjusted for demographics, cardiac risk factors, and HIV-related and inflammatory biomarkers. RESULTS: Mean (SD) age was 60.1 (11.9) years among HIV- and 54.2 (11.2) years among HIV+ participants (P<0.001), 83% of whom had undetectable (<20 copies/mL) HIV-1 viral load (VL). In comparison with HIV- men, HIV+ men had higher QTVI (adjusted difference of +0.077 [95% CI, +0.032 to +0.123]). The magnitude of this association depended on the degree of viremia, such that in HIV+ men with undetectable VL, adjusted QTVI was +0.064 (95% CI, +0.017 to +0.111) higher than in HIV- men, whereas, in HIV+ men with detectable VL, adjusted QTVI was higher by +0.150 (95% CI, 0.072-0.228) than in HIV- referents. Analysis of QTVI subcomponents showed that HIV+ men had: (1) lower heart rate variability irrespective of VL status, and (2) higher QT variability if they had detectable, but not with undetectable, VL, in comparison with HIV- men. Higher levels of C-reactive protein, interleukin-6, intercellular adhesion molecule-1, soluble tumor necrosis factor receptor 2, and soluble cluster of differentiation-163 (borderline), were associated with higher QTVI and partially attenuated the association with HIV serostatus. CONCLUSIONS: HIV+ men have greater beat-to-beat variability in QT interval (QTVI) than HIV- men, especially in the setting of HIV viremia and heightened inflammation. Among HIV+ men, higher QTVI suggests ventricular repolarization lability, which can increase susceptibility to arrhythmias, whereas lower heart rate variability signals a component of autonomic dysfunction.
BACKGROUND: People living with human immunodeficiency virus (HIV+) have greater risk for sudden arrhythmic death than HIV-uninfected (HIV-) individuals. HIV-associated abnormal cardiac repolarization may contribute to this risk. We investigated whether HIV serostatus is associated with ventricular repolarization lability by using the QT variability index (QTVI), defined as a log measure of QT-interval variance indexed to heart rate variance. METHODS: We studied 1123 men (589 HIV+ and 534 HIV-) from MACS (Multicenter AIDS Cohort Study), using the ZioXT ambulatory electrocardiography patch. Beat-to-beat analysis of up to 4 full days of electrocardiographic data per participant was performed using an automated algorithm (median analyzed duration [quartile 1-quartile 3]: 78.3 [66.3-83.0] hours/person). QTVI was modeled using linear mixed-effects models adjusted for demographics, cardiac risk factors, and HIV-related and inflammatory biomarkers. RESULTS: Mean (SD) age was 60.1 (11.9) years among HIV- and 54.2 (11.2) years among HIV+ participants (P<0.001), 83% of whom had undetectable (<20 copies/mL) HIV-1 viral load (VL). In comparison with HIV- men, HIV+ men had higher QTVI (adjusted difference of +0.077 [95% CI, +0.032 to +0.123]). The magnitude of this association depended on the degree of viremia, such that in HIV+ men with undetectable VL, adjusted QTVI was +0.064 (95% CI, +0.017 to +0.111) higher than in HIV- men, whereas, in HIV+ men with detectable VL, adjusted QTVI was higher by +0.150 (95% CI, 0.072-0.228) than in HIV- referents. Analysis of QTVI subcomponents showed that HIV+ men had: (1) lower heart rate variability irrespective of VL status, and (2) higher QT variability if they had detectable, but not with undetectable, VL, in comparison with HIV- men. Higher levels of C-reactive protein, interleukin-6, intercellular adhesion molecule-1, soluble tumor necrosis factor receptor 2, and soluble cluster of differentiation-163 (borderline), were associated with higher QTVI and partially attenuated the association with HIV serostatus. CONCLUSIONS: HIV+ men have greater beat-to-beat variability in QT interval (QTVI) than HIV- men, especially in the setting of HIV viremia and heightened inflammation. Among HIV+ men, higher QTVI suggests ventricular repolarization lability, which can increase susceptibility to arrhythmias, whereas lower heart rate variability signals a component of autonomic dysfunction.
Authors: Sherif F Nagueh; Otto A Smiseth; Christopher P Appleton; Benjamin F Byrd; Hisham Dokainish; Thor Edvardsen; Frank A Flachskampf; Thierry C Gillebert; Allan L Klein; Patrizio Lancellotti; Paolo Marino; Jae K Oh; Bogdan Alexandru Popescu; Alan D Waggoner Journal: J Am Soc Echocardiogr Date: 2016-04 Impact factor: 5.251
Authors: Raza M Alvi; Anne M Neilan; Noor Tariq; Malek O Hassan; Magid Awadalla; Lili Zhang; Maryam Afshar; Adam Rokicki; Connor P Mulligan; Virginia A Triant; Markella V Zanni; Tomas G Neilan Journal: JACC Heart Fail Date: 2019-08-07 Impact factor: 12.035
Authors: Ahsan H Khandoker; Mohammad Hasan Imam; Jean-Philippe Couderc; Marimuthu Palaniswami; Herbert F Jelinek Journal: IEEE Trans Inf Technol Biomed Date: 2012-08-24
Authors: Maarten Hulsmans; Sebastian Clauss; Ling Xiao; Aaron D Aguirre; Kevin R King; Alan Hanley; William J Hucker; Eike M Wülfers; Gunnar Seemann; Gabriel Courties; Yoshiko Iwamoto; Yuan Sun; Andrej J Savol; Hendrik B Sager; Kory J Lavine; Gregory A Fishbein; Diane E Capen; Nicolas Da Silva; Lucile Miquerol; Hiroko Wakimoto; Christine E Seidman; Jonathan G Seidman; Ruslan I Sadreyev; Kamila Naxerova; Richard N Mitchell; Dennis Brown; Peter Libby; Ralph Weissleder; Filip K Swirski; Peter Kohl; Claudio Vinegoni; David J Milan; Patrick T Ellinor; Matthias Nahrendorf Journal: Cell Date: 2017-04-20 Impact factor: 41.582
Authors: Gerald S Bloomfield; Isabelle R Weir; Heather J Ribaudo; Kathleen V Fitch; Carl J Fichtenbaum; Laura E Moran; Roger Bedimo; Christopher de Filippi; Caryn G Morse; Jonathan Piccini; Markella V Zanni; Michael T Lu; Udo Hoffmann; Steven K Grinspoon; Pamela S Douglas Journal: J Acquir Immune Defic Syndr Date: 2022-03-01 Impact factor: 3.771
Authors: Gypsyamber D'Souza; Fiona Bhondoekhan; Lorie Benning; Joseph B Margolick; Adebola A Adedimeji; Adaora A Adimora; Maria L Alcaide; Mardge H Cohen; Roger Detels; M Reuel Friedman; Susan Holman; Deborah J Konkle-Parker; Daniel Merenstein; Igho Ofotokun; Frank Palella; Sean Altekruse; Todd T Brown; Phyllis C Tien Journal: Am J Epidemiol Date: 2021-08-01 Impact factor: 5.363
Authors: Irena Andršová; Katerina Hnatkova; Martina Šišáková; Ondřej Toman; Peter Smetana; Katharina M Huster; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik Journal: Diagnostics (Basel) Date: 2020-12-16
Authors: Jessica Robinson-Papp; Varuna Astha; Alexandra Nmashie; Sandeep K Sharma; Seunghee Kim-Schulze; Jacinta Murray; Mary Catherine George; Susan Morgello; Bridget R Mueller; Steven A Lawrence; Emma K T Benn Journal: Brain Behav Immun Health Date: 2020-08-03